Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  News  >  Companies  >  All News

News : Companies
Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors

RayBiotech Launches Worldwide Biological Research Grant Program

share with twitter share with LinkedIn share with facebook
share via e-mail
07/01/2013 | 10:05am EDT

Norcross, GA ? July 1, 2013 - (eTeligis via ACCESSWIRE) -- RayBiotech, Inc. announced today their sponsorship of a new funding opportunity for biomedical science researchers, a program called the "2013 RayBiotech Innovative Research Grant." Terms of the grant program state that eligible topics include studies on model systems for biological processes and disease, biomarker discovery and validation, biomedical and veterinary sciences, biotechnology and biological sciences (including biochemistry, cell biology, genetics, physiology, plant sciences, environmental sciences, nutrition and food sciences). The highest scoring applicants will receive up to $15,000 worth of RayBiotech products, which include antibody arrays, ELISA kits, reagents, and custom services. The grant program is open to researchers worldwide.

RayBiotech's President, Chief Operating Officer and Co-Founder, Rani Huang stated, "We are excited to have the opportunity to give something back to the research community that we serve. Our products have enabled thousands of researchers to describe the molecular basis of disease, resulting in many high-impact publications. This grant program will help us to fulfill our mission of the advancement of personalized medicine." The applicants will be scored on scientific merit, potential impact of the proposed research, and degree of creativity or inventiveness exhibited in the project.

About RayBiotech, Inc.

In 2001 RayBiotech (http://www.raybiotech.com) introduced the first commercially available cytokine antibody array. With a focus on translating scientific knowledge into improved health, RayBiotech continues to pioneer advances in high-throughput platforms for identifying disease mechanisms, screening and validation of biomarkers and identification of drug targets. RayBiotech products are featured in thousands of publications, including: Nature, Nature Medicine, Cell, Lancet, PNAS and many others. Offering the largest selection of protein arrays, RayBiotech has established a reputation for high quality and innovation in the research community. A spin-off from Emory University, RayBiotech is privately owned, with headquarters in the metropolitan Atlanta area.


For More Information:

Rob Burgess, PhD

Director, Business Development

RayBiotech, Inc.

Phone: 770-729-2992

Email: rob@raybiotech.com

SOURCE: RayBiotech, Inc.


© Accesswire 2013
share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news "Companies"
05:28pSUNCOR ENERGY : No injuries as fire aboard Suncor's Terra Nova vessel extinguished
AQ
05:20pGLOBAL EAGLE ENTERTAINMENT : Official notification to shareholders of matters to be brought to a vote ("Proxy")
PU
04:20pTHIN FILM ELECTRONICS ASA : - Registration of Share Capital Increase
AQ
04:16pHAMILTON BEACH BRANDS : ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Reminds Hamilton Beach Brands Holding Company Investors of Important Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm – HBB
BU
04:08pBOEING : Dragon-riding astronauts join exclusive inner circle at NASA
AQ
03:39pTESLA : SpaceX's Rocket Launches Successfully, Approaches Orbit
DJ
03:33pTESLA : SpaceX rocket ship blasts off into orbit with 2 Americans
AQ
03:16pMESA FINAL DEADLINE MONDAY : ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Reminds Mesa Air Group, Inc. Investors of Important June 1 Deadline in First Federal Securities Class Action Filed by the Firm – MESA
BU
03:07pTESLA : Elon Musk's SpaceX Tries Again to Launch NASA Astronauts Into Orbit -- 6th Update
DJ
03:02pElixxer Ltd. Provides Update on Continuous Disclosure Filings Following Temporary Relief by the Canadian Securities Administrators
GL
Latest news "Companies"